Perioperative Articles

This is unpublished

Cardiac Risk Assessment

  • ACC/AHA Guidelines: Fleisher LA, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130(24):2215–45.
  • Canadian CV Risk Assessment Guidelines: Duceppe E, et al. Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery. Can J Cardiol. 2017 Jan;33(1):17–32.
  • RCRI Score Derivation: Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043–1049.
  • CARP Trial: McFalls EO, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med. 2004;351(27):2795–804.
  • Review Article: Devereaux P and Sessler DI. Cardiac complications in patients undergoing major noncardiac surgery. N Engl J Med. 2015;373:2258–2269.
  • NSQIP Calculator: Bilimoria KY, et al. Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg. 2013;217(5):833–42.e1-3. Epub 2013 Sep 18.
  • Perioperative BNP Measurement: Rodseth RN, et al. The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide: a systematic review and individual patient data meta-analysis. J Am Coll Cardiol. 2014;63:170–80.
  • Importance of Functional Status (published by UWMC providers): Reilly DR, et al. Self-reported exercise tolerance and the risk of serious perioperative complications. Arch Int Med.1999;159:2185–2192.

Beta-blockers

  • ACC/AHA Beta-Blocker Guidelines: Wijeysundera DN, Duncan D, Nkonde-Price C, et al. Perioperative betablockade in noncardiac surgery: A systematic review for the 2014 ACC/ AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130:2246–64.
  • POISE Trial: POISE Study Group, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371(9627):1839–47.
  • Benefits/Risks of Beta-Blockers: Lindenauer PK, et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005;353(4):349–61.
  • Benefits/Risks of Beta-Blockers: Friedell ML, et al. β-blockade and operative mortality in noncardiac surgery: harmful or helpful? JAMA Surg. 2015;150(7):658–664.
  • Physiology of Beta-Blockers: London MJ, et al. Perioperative -adrenergic receptor blockade. Anesthesiology. 2004 Jan;100(1):170–5.

Pulmonary Risk Assessment

  • Pulmonary Risk Assessment: Smetana GW, et al. Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians. Ann Intern Med. 2006;144(8):581–95.
  • PERISCOPE Risk Score: Canet J, et al. Development and validation of a score to predict postoperative respiratory failure in a multicentre European cohort: A prospective, observational study. European Journal of Anaesthesiology. 2015;32(7), 458–470.

Stroke Risk Assessment

  • Timing of Surgery after CVA: Jorgensen ME, et al. Time elapsed after ischemic stroke and risk of adverse cardiovascular events and mortality following elective noncardiac surgery. JAMA. 2014;312(3):269–277.